- Report
- March 2025
- 120 Pages
North America
From €3537EUR$4,000USD£3,053GBP
- Report
- August 2024
- 80 Pages
United States
From €3095EUR$3,500USD£2,672GBP
- Report
- May 2025
- 84 Pages
United States
From €3095EUR$3,500USD£2,672GBP
- Report
- October 2024
- 114 Pages
North America
From €3050EUR$3,450USD£2,633GBP
- Report
- October 2024
- 109 Pages
Africa, Middle East
From €3050EUR$3,450USD£2,633GBP
- Report
- October 2024
- 126 Pages
Europe
From €3050EUR$3,450USD£2,633GBP
- Report
- May 2025
- 145 Pages
United States
From €2210EUR$2,500USD£1,908GBP
- Report
- March 2025
- 99 Pages
Europe
From €3050EUR$3,450USD£2,633GBP
- Report
- March 2025
- 88 Pages
North America
From €2608EUR$2,950USD£2,252GBP
- Report
- January 2024
- 459 Pages
Global
From €6322EUR$7,150USD£5,458GBP
- Report
- March 2024
- 278 Pages
Global
From €4377EUR$4,950USD£3,778GBP
- Report
- March 2023
- 281 Pages
Global
From €2971EUR$3,360USD£2,565GBP
€3713EUR$4,200USD£3,206GBP
- Report
- June 2022
- 264 Pages
Global
From €2476EUR$2,800USD£2,137GBP
€3095EUR$3,500USD£2,672GBP
- Report
- May 2022
- 291 Pages
Global
From €2652EUR$3,000USD£2,290GBP
€3316EUR$3,750USD£2,862GBP
- Report
- August 2024
- 322 Pages
Global
From €2166EUR$2,450USD£1,870GBP
- Report
- February 2024
- 111 Pages
Global
From €4111EUR$4,650USD£3,549GBP
- Report
- February 2023
- 184 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- January 2023
- 66 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- August 2024
- 322 Pages
Global
From €2971EUR$3,360USD£2,565GBP
€3713EUR$4,200USD£3,206GBP
- Report
- August 2024
- 149 Pages
Global
From €2652EUR$2,999USD£2,289GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more